Background: Second-generation antipsychotics (SGAs) are thought to have a lower likelihood of inducing extrapyramidal symptoms (EPS) than are first-generation antipsychotics (FGAs). Clinical ...
Oct. 2, 2003 — Olanzapine was associated with the fewest patients with extrapyramidal symptoms (EPS) at six months compared with baseline, according to the results of a large prospective trial ...
Credit: Getty Images. Extrapyramidal symptoms that developed in patients with schizophrenia after initiation of treatment with atypical antipsychotic agents were associated with increased healthcare ...
This study presents a meta-analysis of the influence of several potentially biasing factors (eg industry support, extrapyramidal side effects) on efficacy of studies comparing second-generation ...
Pharmacogenetics has been driven by a candidate gene approach. 4 The disadvantage of this approach is that the objects of study are circumscribed by our current understanding of the mechanisms by ...
New research illuminates the benefits and risks of antipsychotic medication in children and its impact on individual well-being, social, educational and/or vocational functioning, and disease burden.
Any patient on a dopamine receptor-blocking medication may develop tardive dyskinesia (TD), though most often the condition is associated with antipsychotic medications. "You would be ill-advised to ...
The FDA has notified healthcare professionals that it has updated the Pregnancy section of the labeling for the entire class of antipsychotic drugs. The new drug labeling now provides additional ...
NEW YORK, Jan. 21, 2021 (GLOBE NEWSWIRE) -- In t ra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central ...
Antipsychotic drugs are used to treat symptoms of psychiatric disorders, such as bipolar disorder and schizophrenia. The new labeling standards are for older antipsychotic drugs as well as newer ones.
If at all pregnant women take antipsychotic drugs, it should be only under the supervision of a physician who can manage any potential adverse effects in the fetus. A new safety warning regarding the ...